Background: In the past few years, COVID-19 became the leading cause of morbidity and
mortality worldwide. Although the World Health Organization has declared an end to COVID …

Background COVID 19, a lethal viral outbreak that devastated lives and the economy across
the globe witnessed non-compensable respiratory illnesses in patients. As been evaluated …

At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

Pulmonary fibrosis (PF) is characterised by several grades of chronic inflammation and
collagen deposition in the interalveolar space and is a hallmark of interstitial lung diseases …

Pulmonary fibrosis is characterized by extracellular deposition in the lung primarily collagen
but also other ECM molecules. The primary cell type responsible for this is the myofibroblast …

The pathogenetic mechanism of post-Covid-19 pulmonary fibrosis is currently a topic of
intense research interest, but still largely unexplored. The aim of this work was to carry out a …

In 2019, an unprecedented disease named coronavirus disease 2019 (COVID-19) emerged
and spread across the globe. Although the rapid transmission of COVID-19 has resulted in …

Abstract Coronavirus disease 2019 (COVID-19) is caused by a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The most common cause of …

Introduction Lung injury in severe COVID-19 pneumonia can rapidly evolve to established
pulmonary fibrosis, with prognostic implications in the acute phase of the disease and long …